BreachRx SPV2, LLC is a private investment fund based in Atlanta, Georgia. According to its most recent Form D, filed Feb 25, 2026, it has sold $295,625 of interests to 4 investors since its first sale in Jul 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Overline, LLC.
- Total raised
- $295,625Cumulative sales reported on Form D
- Investors
- 4
- First sale
- Jul 15, 2025
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Overline, LLC
- Latest Form D
- Feb 25, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about BreachRx SPV2, LLC
What is the minimum investment for BreachRx SPV2, LLC?
BreachRx SPV2, LLC's latest Form D, filed Feb 25, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in BreachRx SPV2, LLC?
BreachRx SPV2, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has BreachRx SPV2, LLC raised?
BreachRx SPV2, LLC reports $295,625 sold from 4 investors on its Form D filed Feb 25, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is BreachRx SPV2, LLC based?
BreachRx SPV2, LLC is based in Atlanta, Georgia and is managed by Overline.
When did BreachRx SPV2, LLC launch?
BreachRx SPV2, LLC reports its first sale in Jul 2025, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every private investment fund
Raised more than 12% of the 237 private investment funds based in Georgia, and more than 6% of all 10,270 that report sales.